Arlene Goldenberg
Vice President, Investor Relations, REPLIMUNE
Replay available
Replimune Group, Inc. (REPL) Q4 2025 Earnings Call
Replimune Group, Inc. (NASDAQ: REPL) Q4 2025 earnings conference call, held 2025-05-22. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Emily Hill
Chief Financial Officer, REPLIMUNE
Allison Bratzel
Analyst, Piper Sandler
Roger Song
Analyst, Jefferies
Jonathan Chang
Analyst, Learing Partners
Sushil Patel
Chief Executive Officer, REPLIMUNE
Chris Salke
Chief Commercial Officer, REPLIMUNE
Peter Lawson
Analyst, Barclays
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Replimune Group, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.259 Good morning and welcome to the REPLIMUNE fiscal year fourth quarter 2025 financial 00:00:05.259 -- 00:00:07.782 results and corporate update conference call. 00:00:07.782 -- 00:00:10.626 Currently, all participants are on listen-only mode. 00:00:10.626 -- 00:00:15.493 This call is being webcast live on the investors and media section of REPLIMUNE's website 00:00:15.493 -- 00:00:17.076 at REPLIMUNE.com, 00:00:17.076 -- 00:00:19.800 and a recording will be available after the call. 00:00:19.800 -- 00:00:23.024 I would like to introduce Arlene Goldenberg from REPLIMUNE. 00:00:23.024 -- 00:00:25.465 Please go ahead. 00:00:25.909 -- 00:00:28.432 Thank you, operator, and good morning, everyone. 00:00:28.432 -- 00:00:33.537 Thank you for joining us today for a discussion of Replicant's fiscal year fourth quarter 00:00:33.537 -- 00:00:37.842 2025 business highlights and financial results. 00:00:37.842 -- 00:00:42.807 Leading the call today will be Sushil Patel, our Chief Executive Officer. 00:00:42.807 -- 00:00:47.532 He will be joined by Chris Sarkey, our Chief Commercial Officer, and Emily Hill, our 00:00:47.532 -- 00:00:52.657 Chief Financial Officer. After our prepared remarks, we will open the call for 00:00:52.657 -- 00:00:58.020 Q&A. An audio recording and webcast replay for today's conference call 00:00:58.020 -- 00:01:03.124 will also be available online as detailed in the press release announcement for 00:01:03.124 -- 00:01:04.886 this call. 00:01:04.886 -- 00:01:09.850 During today's call, we will be making certain forward-looking statements, including, 00:01:09.850 -- 00:01:14.915 without limitation, statements about the potential safety, efficacy, and 00:01:14.915 -- 00:01:20.239 regulatory and clinical progress of our produc...